Giulia Micoli
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Biological features associated with poor response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 17, 2026
Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancer.
Journal: Genome medicine
Published: February 12, 2026
Decoding the Genomic and Functional Landscape of Emerging Subtypes in Ovarian Cancer.
Journal: Cancer discovery
Published: April 14, 2025
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer.
Journal: Cell reports. Medicine
Published: February 03, 2025
Dynamic and Ongoing De Novo L1 Retrotransposition Contributes to Genome Plasticity and Intrapatient Heterogeneity in Ovarian Cancer.
Journal: Cancer research
Published: November 25, 2024
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer.
Journal: bioRxiv : the preprint server for biology
Published: April 02, 2024
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer.
Journal: Cancer cell
Published: March 18, 2024
Deciphering cancer genomes with GenomeSpy: a grammar-based visualization toolkit.
Journal: GigaScience
Published: January 09, 2024
HRD related signature 3 predicts clinical outcome in advanced tubo-ovarian high-grade serous carcinoma.
Journal: Gynecologic oncology
Published: August 13, 2023
H&E image analysis pipeline for quantifying morphological features.
Journal: Journal of pathology informatics
Published: May 25, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026